Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievalble oocytes after ovarian stimulation

Find Full text
Publication year
2000
Author(s)
Out, H.J.
Braat, D.D.M.
Lintsen, A.M.E.
Gurgan, T.
Bukulmez, O.
Gokmen, O.
Kelez, G.
Caballero, P.
González, J.M.
Gabregues, F.
Balasch, J.
Roulier, R.
Source
Human Reproduction, 15, 1, (2000), pp. 29-35
ISSN
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/144816   https://hdl.handle.net/2066/144816
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.